Notably, the upregulation of HDAC6 expression in osteoblasts has been shown to promote osteoarthritis (OA) progression, suggesting that HDAC6 inhibitors hold promise as potential therapeutic agents for OA [158]. This evidence concerns the gene HDAC6 and osteoarthritis.